Alder Mix
NDC 49643-501, Alnus rhombifolia/Alnus rubra/Alnus rugosa, liquid, from Allermed Laboratories, Inc..
- Product NDC
- 49643-501
- Status
- Listed
- Labeler
- Allermed Laboratories, Inc.
- Dosage form
- LIQUID
- Route
- PERCUTANEOUS, SUBCUTANEOUS
- Product type
- NON-STANDARDIZED ALLERGENIC
- Marketing category
- BLA
- Application
- BLA102211
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49643-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALNUS RHOMBIFOLIA POLLEN.0167 g/mL
- ALNUS RUBRA POLLEN.0167 g/mL
- ALNUS INCANA SUBSP. RUGOSA POLLEN.0167 g/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49643-501-05 | 49643050105 | 5 mL in 1 VIAL, MULTI-DOSE (49643-501-05) |
| 49643-501-10 | 49643050110 | 10 mL in 1 VIAL, MULTI-DOSE (49643-501-10) |
| 49643-501-30 | 49643050130 | 30 mL in 1 VIAL, MULTI-DOSE (49643-501-30) |
| 49643-501-50 | 49643050150 | 50 mL in 1 VIAL, MULTI-DOSE (49643-501-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 49643-501 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49643-501 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49643-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.